glp-1 regulations Beyond Agonists: An Adaptive Ketogenic–Mediterranean Protocol to Counter Metabolic Adaptation in Obesity Management Messaged provider re: GLP-1 discontinuation

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may be a practical, adjunctive treatment option for patients with psoriasis and metabolic comorbidities, according to The National Psoriasis Foundation Primer on GLP-1 Receptor Agonists in Psoriasis: A Review, which appears in JAMA Dermatology

When you have bipolar disorder, its always a good idea to track your symptoms

Clinical implications: Multiple companies are developing muscle-preserving therapies, suggesting this will be an active area of development

Direct RA outcome data is growing, and it was one of the two medications used in the UCLA RA study

Heart attacks and strokes are down 20%